Journals / Annals of Medical Research / 2022 / Cilt: 29 - Sayı: 2

Vitamin D deficiency and clinical severity of Covid-19 infection

Pages
134–138
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Vitamin D levels should be brought to optimal levels.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: COVID-19 infection which emerged at Wuhan, China in 2019 has been continuing to cause major morbidity and mortality.
📊
Key Findings & Data:Vaccination, targeted drug therapy, protective measures and immune system modulation with supportive treatment are desperately needed against this viral pathogen caused international pandemic.
💡
Conclusion & Impact:Vitamin D levels should be brought to optimal levels.
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters

Abstract

Aim: COVID-19 infection which emerged at Wuhan, China in 2019 has been continuing to cause major morbidity and mortality. Vaccination, targeted drug therapy, protective measures and immune system modulation with supportive treatment are desperately needed against this viral pathogen caused international pandemic. Vitamin D is a secosteroid which has immunomodulator, antiinflammatory, antifibrotic and antioxidant properties. At this study we aimed to investigate correlation between Vitamin D deficiency and disease severity. Materials and Methods: 225 patients who needed hospitalization has been inducted to the study. Vitamin D levels were measured at the acute period of disease. Patients were divided to two groups; service (n:163) and intensive care (n:62) and mean vitamin D levels between these two groups were compared. Vitamin D levels were classified as follows; severe deficiency: Vitamin≤30 and normal level: vitamin D 30-80 nmol/L. Correlation between Vitamin D level and acute phase reactants which shows infection severity such as Complete blood count, sedimentation, C reactive protein, fibrinogen, ferritin, D-Dimer were investigated. Results: There was a severe vitamin D deficiency at both service and intensive care groups. Intensive care group had statistically significant lower vitamin D level compared to service group. There was a negative correlation between vitamin D and white blood cell, neutrophil count. Conclusion: There is a correlation between vitamin D deficiency and COVID 19 clinical severity. This is a modifiable risk factor and vitamin D treatment should be given at both acute disease and preventive treatment. Vitamin D levels should be brought to optimal levels.

🔖

Cite This Article

YÜCEL, H. E., ERBEŞLER, Z. A., TUR, K., ÇELİKER, M., KONAR, N. M., UÇAR, C. (2022). Vitamin D deficiency and clinical severity of Covid-19 infection. Annals of Medical Research, Cilt: 29 - Sayı: 2, 134–138. https://ajindex.com/articles/445639

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Adhikari SP, Meng S, Wu Y-J, Mao Y-P, Ye R-X, Wang Q-Z, et al. Epidemiology, causes, clinicalmanifestationanddiagnosis, preventionandcontrol of coronavirusdisease (COVID-19) duringtheearlyoutbreakperiod: a scopingreview. InfectiousDiseases of Poverty. 2020;9(1):1-12
  2. Chen N.,Zhou M., Dong X., Qu J., Gong F., Han Y., Qiu Y., Wang J., Liu Y., Wei Y., et al. Epidemiologicalandclinicalcharacteristics of 99 cases of 2019 novelcoronaviruspneumonia in Wuhan, China: A descriptivestudy. Lancet. 2020;395:507–513
  3. Yang J.,Zheng Y., Gou X., Pu K., Chen Z., Guo Q., Ji R., Wang H., Wang Y., Zhou Y.-N. Prevalence of comorbiditiesanditseffects in patientsinfectedwith SARS-CoV-2: A systematicreviewand meta-analysis. Int. J. Infect. Dis. 2020;94:91–95
  4. Liu C, Zhou Q, Li Y, Garner LV, Watkins SP, Carter LJ, et al. Researchanddevelopment on therapeuticagentsandvaccinesfor COVID-19 andrelatedhumancoronavirusdiseases. ACS Publications; 2020
  5. Jawhara S. CouldInt 5. Jawhara S. Could Intravenous Immunoglobulin Collected from Recovered Coronavirus Patients Protect against COVID-19 and Strengthen the Immune System of New Patients? International Journal of MolecularSciences. 2020;21(7):2272
  6. Shi Y.,Yu X., Zhao H., Wang H., Zhao R., Sheng J. Host susceptibilityto severe COVID-19 andestablishment of a host risk score: Findings of 487 casesoutsideWuhan. Crit. Care. 2020;24:1–4
  7. Smailnejad Ganji K, Mohammadzadeh I, Mohammadnia-Afrouzi M, Ebrahimpour S, Shahbazi M. Factorsaffectingimmuneresponsestovaccines. GAZZETTA MEDICA ITALIANA ARCHIVIO PER LE SCIENZE MEDICHE. 2018;177(5):219-28 8. Harris, M. D. (2011). Infectiousdisease in athletes. Curr Sports MedRep, 10(2), 84-89
  8. Unger WW, Laban S, Kleijwegt FS, van der Slik AR, Roep BO. Induction of Tregbymonocyte- derived DC modulatedby vitamin D3 ordexamethasone: differential role for PD- L1. Europeanjournal of immunology. 2009;39(11):3147-59
  9. Ferreira GB, Vanherw 10. Van Etten E, Mathieu C. Immunoregulationby 1,25- dihydroxy1,25(OH)2D3: basicconcepts. J SteroidBiochemMolBiol. 2005;97:93–101
  10. Dankers W.,Colin E. M., van Hamburg J. P., Lubberts E. Vitamin D in autoimmunity: molecularmechanismsandtherapeuticpotential. Front Immunol. 2017;7:697
  11. Infante M., Ricordi C., Sanchez J., Clare-Salzler M. J., Padilla N., Fuenmayor V. Influence of vitamin d on isletautoimmunityand beta-cellfunction in type 1 diabetes. Nutrients. 2019;11:2185
  12. Gombart A. F., Borregaard N., Koeffler H. P. Human cathelicidinantimicrobia